Detalhe da pesquisa
1.
Pirfenidone inhibits TGF-ß1-induced metabolic reprogramming during epithelial-mesenchymal transition in non-small cell lung cancer.
J Cell Mol Med
; 28(3): e18059, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38140828
2.
Pirfenidone suppressed triple-negative breast cancer metastasis by inhibiting the activity of the TGF-ß/SMAD pathway.
J Cell Mol Med
; 27(3): 456-469, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651490
3.
Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway.
BMC Urol
; 22(1): 79, 2022 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35610639
4.
MPEG-PCL Nanomicelles Platform for Synergistic Metformin and Chrysin Delivery to Breast Cancer in Mice.
Anticancer Agents Med Chem
; 22(2): 280-293, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34165412
5.
Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer.
J Oncol
; 2021: 2939162, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34539781
6.
Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer.
Medicine (Baltimore)
; 98(52): e18513, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876741